“Gleevec generics have no bioequivalent problem, and prescribing is a matter of the medical field”
The Ministry of Food and Drug Safety(MFDS) made straight that there was no problem for the Gleevec generics’ bioequivalence test in safety and efficacy, but prescribing generics over Gleevec is not a matter of issue that the MFDS could get involved in.
This was confirmed at the Minister Young-Ji...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
